SHH:688117

ChengDu ShengNuo Biotec Co.,Ltd. · SHH · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:46 UTC

Last close

n/aCNY

Market data

  • 15.0xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 21.3%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 4.4%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.5%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • computed

Follow one yuan

lens 1 of 9
After what it costs to make
100%
After running the business
27.1%
After interest and tax
21.3%
After what it must reinvest
4.4%
Kept after the dividend
-0.4%
after what it costs to make, 100.0% of sales; after running the business, 27.1% of sales; after interest and tax, 21.3% of sales; after what it must reinvest, 4.4% of sales; kept after the dividend, -0.4% of sales

The five stops

5 of 5 read
  • After what it costs to make741,343,445100%
  • After running the business200,844,66127.1%
  • After interest and tax157,924,37321.3%
  • After what it must reinvest32,679,1964.4%
  • Kept after the dividend-3,315,909-0.4%

Of every unit of sales, -0.00 is still there after the dividend.

Of every unit of sales, -0.00 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales741,343,445
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • After what it costs to make741,343,445
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • After running the business200,844,661
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • After interest and tax157,924,373
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • After what it must reinvest32,679,196
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Kept after the dividend-3,315,909
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.